Found 24 matching trials
Tesamorelin Effects on Liver Fat and Histology in HIV
NALiver disease is one of the leading co-morbidities of human immunodeficienc...
Location
National Institutes of Health
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
PHASE2Obesity, a condition that occurs when a person has too much body fat, affec...
Location
Massachusetts General Hospital
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
PHASE2Nonalcoholic fatty liver disease (NAFLD) is common in individuals with obes...
Location
Massachusetts General Hospital
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
PHASE3Assessing the Efficacy and Long-Term Safety of a 2 mg dose of TH9507, a Gro...
Location
University of Alabama at Birmingham
Effects of Growth Hormone Releasing Hormone in HIV
NAHIV-infection and its treatment are often associated with an increase in be...
Location
Massachusetts General Hospital
Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue
NAObesity is strongly associated with risk of cardiovascular disease (CVD). D...
Location
Massachusetts General Hospital
Growth Hormone Dynamics and Cardiac Steatosis in HIV
N/ACardiac steatosis is increased among individuals with HIV, and may predispo...
Location
Massachusetts General Hospital
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
PHASE2This randomized, double-blind, placebo-controlled Phase II study evaluates ...
Location
Peking University Shenzhen Hospital
Effects of Short-term Growth Hormone in HIV-infected Patients
NAThe purpose of this study is to examine the short-term effects of two diffe...
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
PHASE2The aim of this study is to test whether tesamorelin, in combination with a...
Location
Keck School of Medicine of the University of Southern California